Phreesia (PHR)
(Delayed Data from NYSE)
$23.76 USD
+0.44 (1.89%)
Updated Sep 12, 2024 04:00 PM ET
After-Market: $23.77 +0.01 (0.04%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth C Momentum A VGM
Brokerage Reports
0 items in cart
Phreesia, Inc. [PHR]
Reports for Purchase
Showing records 1 - 20 ( 170 total )
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Profits Cash Generation Clearly in Focus; See Pathway to Consistent 15%+ Growth at MSD Margins
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Phreesia, Inc.
Industry: Medical Info Systems
Top- and Bottom-Line Beat; Pushes Out Initial FY25 Revenue Guidance to FY26
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Proprietary Healthcare - Credit Card Transaction Data
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Continue to Like the 2H + FY25 Setup on Multi-Pronged Platform with Growth from Higher-Margin Contributions; Remain OW
Provider: KeyBanc Capital Markets
Analyst: Research Department